Twenty years of deep cultivation in medicine empowers global health

In the current era of accelerated integration of the global health industry, a safe and compliant product system, full chain R&D and production capabilities, and an international service perspective have become the core competitiveness for pharmaceutical companies to establish themselves in the global market. Yangling Jitai Pharmaceutical Co., Ltd., Xi'an Jitai Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Jitai Pharmaceutical") and its wholly-owned subsidiary Shaanxi Yipaxin Pharmaceutical Co., Ltd. (hereinafter referred to as "Yipaxin"), relying on more than 20 years of deep cultivation and accumulation in the pharmaceutical field, have built a diversified business ecosystem covering active pharmaceutical ingredients, formulations, and beauty and health products, providing safe and reliable high-quality pharmaceutical and health solutions for global customers and consumers.

Full chain layout: integrated strength from research and development to production

Our development foundation began with the establishment of Xi'an Jitai Pharmaceutical Technology Co., Ltd. in 2002. As a start-up enterprise for international students, it focuses on the research and development, drug consistency evaluation, and registration application of traditional Chinese medicine, chemical medicine, and biological products, laying a solid technical foundation for the group. In 2017, Jitai Pharmaceutical was officially established with a registered capital of 60 million yuan. It has built a modern production base covering an area of 50 acres, undertaking the functions of new product pilot testing and simulated production. It has formed a complete drug preclinical research system and clinical biological sample analysis and testing system for compound synthesis, separation, analysis and testing, and formulation research. It is a production and research and development integrated enterprise that strictly follows GMP standards.

In 2020, the establishment of Epassion marked a further expansion of its business territory, extending its scope to the production and sales of beauty food, cosmetics, and health products, as well as the sales of raw materials and drugs, achieving full coverage from the professional pharmaceutical field to daily health scenarios. Nowadays, the three major entities are working together: Xi'an Jitai focuses on research and development innovation, Jitai Pharmaceutical ensures production quality control, and Ipa Xin links to the terminal market, building a seamless layout of the entire industry chain of "research and development production sales", providing efficient and collaborative service support for global cooperation.

R&D driven: Building core advantages through technological innovation

Innovation is the core vitality of pharmaceutical enterprises. We always place R&D investment at a strategic level. Xi'an Jitai Pharmaceutical Technology Co., Ltd. is equipped with a 1000 square meter professional R&D laboratory and has purchased more than 60 sets of advanced research equipment and instruments, with a total value of nearly 20 million yuan, providing solid hardware support for technological breakthroughs and product innovation. The R&D team has been deeply involved in the fields of traditional Chinese medicine, chemical medicine, and biological products, accumulating rich experience in drug research and development, consistency evaluation, technical services, and registration applications. Multiple technological achievements have been successfully transformed into industrialized products.

At the same time, we actively build a platform for industry university research cooperation, establish deep cooperation with Northwest University, a key construction university of the national "211 Project", and list the "Pharmaceutical Engineering Professional Internship Base" and "Professional Degree Graduate Joint Training Practice Base". With the help of the university's scientific research resources and talent advantages, we continuously improve our technological innovation capabilities and inject continuous power into product iteration and industrial upgrading.

Quality assurance: Compliance system escorts global trust

The safety of drugs and health products is related to the well-being of life and is an unbreakable bottom line for us. Jitai Pharmaceutical has obtained the "Drug Production License" issued by the Shaanxi Provincial Drug Administration, covering the production of raw materials such as oseltamivir phosphate and tadalafil. All production processes strictly follow the national GMP standards. Yipaxin ensures that its products meet national quality standards and provide safe and reliable high-quality products to the market through complete approval documents and compliant production processes.

From raw material procurement, research and development testing, production and manufacturing to finished product inspection, warehousing and logistics, we have established a full lifecycle quality control system. Through refined management and rigorous testing processes, we ensure that every batch of products meets internationally recognized quality standards and win the trust of global customers and consumers with compliance strength.

Twenty years of deep cultivation without interruption, the original intention is like a rock. In the future, Jitai Pharmaceutical and Yipaxin will continue to focus on "professionalism and innovation", continuously optimize the layout of the entire industry chain, strengthen research and development innovation and quality control, expand global cooperation networks, and strive to provide better pharmaceutical products and health solutions for global customers, contributing Chinese strength to safeguarding human life and health and promoting the development of the global health industry.